The Current Ratio as of December 2024 (TTM) for ImmuCell Corporation (ICCC) is 3.11

According to ImmuCell Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 3.11. This represents a change of 14.22% compared to the average of 2.72 of the last 4 quarters.

ImmuCell Corporation (ICCC) Historical Current Ratio (quarterly & annually)

How has ICCC Current Ratio performed in the past?

The mean historical Current Ratio of ImmuCell Corporation over the last ten years is 5.27. The current 3.11 Current Ratio has changed 5.81% with respect to the historical average. Over the past ten years (40 quarters), ICCC's Current Ratio was at its highest in in the March 2016 quarter at 14.88. The Current Ratio was at its lowest in in the September 2017 quarter at 1.75.

ImmuCell Corporation (ICCC) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ImmuCell Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ImmuCell Corporation (ICCC) Average Current Ratio

How has ICCC Current Ratio performed in the past?

The current Current Ratio of ImmuCell Corporation (ICCC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ImmuCell Corporation (ICCC) Current Ratio vs. Peers

How is ICCC’s Current Ratio compared to its peers?

ImmuCell Corporation’s Current Ratio is greater than Transgene SA (1.57), greater than Alpha Cognition Inc. (1.50), less than Fennec Pharmaceuticals Inc. (7.80), less than Lipella Pharmaceuticals Inc. (2.97K), less than Eliem Therapeutics, Inc. (0), less than Cyteir Therapeutics, Inc. (21.89), less than Anebulo Pharmaceuticals, Inc. (3.45), greater than HCW Biologics Inc. (0.07), less than MediciNova, Inc. (16.66), greater than AgeX Therapeutics, Inc. (0.64), greater than Lineage Cell Therapeutics, Inc. (2.48), less than Cadrenal Therapeutics, Inc. Common Stock (3.69), less than Oxford Nanopore Technologies plc (4.45), less than Rezolute, Inc. (13.79), less than XOMA Corporation (7.52), greater than Protagenic Therapeutics, Inc. (1.80), greater than Tempest Therapeutics, Inc. (1.69),

Build a custom stock screener for ImmuCell Corporation (ICCC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmuCell Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmuCell Corporation (ICCC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmuCell Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.